• 1
    Cardenas A, Gines P, Uriz J, et al. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis. Hepatology 2001; 34: 6716.
  • 2
    Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int 1998; 54: 51824.
  • 3
    Terra C, Guevara M, Torre A, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 2005; 129: 194453.
  • 4
    Baliga P, Merion RM, Turcotte JG, et al. Preoperative risk factor assessment in liver transplantation. Surgery 1992; 112: 70410.
  • 5
    Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of Orthotopic Liver Transplant (OLTX) in the US: where will MELD lead us? Am J Transplant 2006; 6: 26516.
  • 6
    Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003; 362: 181927.
  • 7
    Arroyo V, Terra C, Gines P. New treatments of hepatorenal syndrome. Semin Liver Dis 2006; 26: 25464.
  • 8
    Moreau R, Durand F, Poynard T, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002; 122: 92330.
  • 9
    Pham PT, Pham PC, Rastogi A, Wilkinson AH. Review article: current management of renal dysfunction in the cirrhotic patient. Aliment Pharmacol Ther 2005; 21: 94961.
  • 10
    Fasolato S, Angeli P, Dallagnese L, et al. Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features. Hepatology 2007; 45: 2239.
  • 11
    Moller S, Henriksen JH. Review article: pathogenesis and pathophysiology of hepatorenal syndrome–is there scope for prevention? Aliment Pharmacol Ther 2004; 20 (Suppl. 3): 3141.
  • 12
    Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341: 4039.
  • 13
    Freeman RB. MELD: the holy grail of organ allocation? J Hepatol 2005; 42: 1620.
  • 14
    Wiesner R, Edwards E, Freeman R. Model for End Stage Liver Disease (MELD) and allocation of donor livers. Gastroenterology 2003; 124: 916.
  • 15
    Cholongitas E, Marelli L, Kerry A, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Transpl 2007; 13: 5239.
  • 16
    Seronie-Vivien S, Galteau MM, Carlier MC, et al. Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum. Clin Chem Lab Med 2005; 43: 122733.
  • 17
    Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med 1988; 39: 46590.
  • 18
    Gaspari F, Perico N, Remuzzi G. Measurement of glomerular filtration rate. Kidney Int Suppl 1997; 63: S1514.
  • 19
    Frennby B, Sterner G, Almen T, Hagstam KE, Hultberg B, Jacobsson L. The use of iohexol clearance to determine GFR in patients with severe chronic renal failure–a comparison between different clearance techniques. Clin Nephrol 1995; 43: 3546.
  • 20
    Gaspari F, Perico N, Ruggenenti P, et al. Plasma clearance of nonradioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 1995; 6: 25763.
  • 21
    Myers GL, Miller WG, Coresh J, et al. Recommendations for Improving Serum Creatinine Measurement: A Report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 518.
  • 22
    Mariat C, Alamartine E, Barthelemy JC, et al. Assessing renal graft function in clinical trials: can tests predicting glomerular filtration rate substitute for a reference method? Kidney Int 2004; 65: 28997.
  • 23
    Moore AE, Park-Holohan SJ, Blake GM, Fogelman I. Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent. Eur J Nucl Med Mol Imaging 2003; 30: 48.
  • 24
    Lamb EJ, O’Riordan SE, Delaney MP. Kidney function in older people: pathology, assessment and management. Clin Chim Acta 2003; 334: 2540.
  • 25
    Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 3141.
  • 26
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 46170.
  • 27
    Mukherjee A, O’Donaghue D, Redenski A, New J, Twomey P. Estimated glomerular filtration rate needs UK consensus. BMJ 2006; 332: 794.
  • 28
    Vickery S, Stevens PE, Dalton RN, Lente FV, Lamb EJ. Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol Dial Transplant 2006; 21: 243945.
  • 29
    Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003; 163: 35660.
  • 30
    Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 193353.
  • 31
    Lamb EJ, Tomson CR, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005; 42: 32145.
  • 32
    Tietz NW, Shuey DF, Wekstein DR. Laboratory values in fit aging individuals – sexagenarians through centenarians. Clin Chem 1992; 38: 116785.
  • 33
    Duncan L, Heathcote J, Djurdjev O, Levin A. Screening for renal disease using serum creatinine: who are we missing? Nephrol Dial Transplant 2001; 16: 10426.
  • 34
    Proulx NL, Akbari A, Garg AX, Rostom A, Jaffey J, Clark HD. Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Transplant 2005; 20: 161722.
  • 35
    Hood B, Attman PO, Ahlmen J, Jagenburg R. Renal hemodynamics and limitations of creatinine clearance in determining filtration rate in glomerular disease. Scand J Urol Nephrol 1971; 5: 15461.
  • 36
    Jacobson HR. Altered permeability in the proximal tubule response to cyclic AMP. Am J Physiol 1979; 236: F719.
  • 37
    Goldberg TH, Finkelstein MS. Difficulties in estimating glomerular filtration rate in the elderly. Arch Intern Med 1987; 147: 14303.
  • 38
    Gonwa TA, Jennings L, Mai ML, Stark PC, Levey AS, Klintmalm GB. Estimation of glomerular filtration rates before and after orthotopic liver transplantation: evaluation of current equations. Liver Transpl 2004; 10: 3019.
  • 39
    Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 24754.
  • 40
    Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 92937.
  • 41
    Kletzel M, Pirich L, Haut P, Cohn RA. Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation. Pediatr Transplant 2005; 9: 5848
  • 42
    Gaspari F., Ferrari S, Stucchi N, et al. Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant 2004; 4: 182635.
  • 43
    Walser M. Assessing renal function from creatinine measurements in adults with chronic renal failure. Am J Kidney Dis 1998; 32: 2331.
  • 44
    Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13: 21404.
  • 45
    Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR – history, indications, and future research. Clin Biochem 2005; 38: 18.
  • 46
    Cholongitas E, Marelli L, Kerry A, et al. Female liver transplant recipients with the same GFR as male recipients have lower MELD scores – a systematic bias. Am J Transplant 2007; 7: 68592.
  • 47
    Kanwal F, Dulai G, Gralnek I, Han S, Spiegel B. The impact of gender on access to liver transplantation in the MELD era. Gastroenterology 2005; 128: A-701.
  • 48
    Freeman RB. Reply. J Hepatol 2005; 42: 4789.
  • 49
    Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 8518.
  • 50
    Massey D. Commentary: clinical diagnostic use of cystatin C. J Clin Lab Anal 2004; 18: 5560.
  • 51
    Mazur MJ, Heilman RL. Early detection of acute renal failure by serum cystatin C: a new opportunity for a hepatologist. Liver Transpl 2005; 11: 7057.
  • 52
    O’Riordan SE, Webb MC, Stowe HJ, et al. Cystatin C improves the detection of mild renal dysfunction in older patients. Ann Clin Biochem 2003; 40: 64855.
  • 53
    Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 2216.
  • 54
    Woitas RP, Stoffel-Wagner B, Flommersfeld S, et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000; 46: 7125.
  • 55
    Orlando R, Mussap M, Plebani M, et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem 2002; 48: 8508.
  • 56
    Demirtas S, Bozbas A, Akbay A, Yavuz Y, Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 819.
  • 57
    Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50: 10610.
  • 58
    Heilman RL, Mazur MJ. Cystatin C as a more sensitive indicator of diminished glomerular filtration rate. Liver Transpl 2005; 11: 2646.
  • 59
    Leung N. A tale of two markers. Liver Transpl 2002; 8: 6002.
  • 60
    Samyn M, Cheeseman P, Bevis L, et al. Cystatin C, an easy and reliable marker for assessment of renal dysfunction in children with liver disease and after liver transplantation. Liver Transpl 2005; 11: 3449.
  • 61
    Schuck O, Gottfriedova H, Maly J, et al. Glomerular filtration rate assessment in individuals after orthotopic liver transplantation based on serum cystatin C levels. Liver Transpl 2002; 8: 5949.
  • 62
    Hermida J, Romero R, Tutor JC. Relationship between serum cystatin C and creatinine in kidney and liver transplant patients. Clin Chim Acta 2002; 316: 16570.
  • 63
    Foster J, Reisman W, Lepage N, Filler G. Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate. Pediatr Nephrol 2006; 21: 2358.
  • 64
    Grubb A, Nyman U, Bjork J, et al. Simple cystatin C-based prediction equations for glomerular filtration rate compared with the modification of diet in renal disease prediction equation for adults and the Schwartz and the Counahan-Barratt prediction equations for children. Clin Chem 2005; 51: 142031.
  • 65
    Grubb A, Bjork J, Lindstrom V, Sterner G, Bondesson P, Nyman U. A cystatin C-based formula without anthropometric variables estimates glomerular filtration rate better than creatinine clearance using the Cockcroft-Gault formula. Scand J Clin Lab Invest 2005; 65: 15362.
  • 66
    Risch L, Huber AR. Assessing glomerular filtration rate in renal transplant recipients by estimates derived from serum measurements of creatinine and cystatin C. Clin Chim Acta 2005; 356: 20411.
  • 67
    Risch L, Drexel H, Huber AR. Differences in glomerular filtration rate estimates by 2 cystatin C-based equations. Clin Chem 2005; 51: 22112.
  • 68
    Podracka L, Feber J, Lepage N, Filler G. Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients. Pediatr Transplant 2005; 9: 2832.
  • 69
    Trotter JF, Brimhall B, Arjal R, Phillips C. Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transpl 2004; 10: 9951000.
  • 70
    Freeman R, Wiesner R, Harper A. The new liver allocation system: moving towards evidence-based transplantation policy. Liver Transpl 2002; 8: 8518.
  • 71
    Howie A, Ferreira M, Adu D. Prognstic value of simple measurement of chronic damage in renal biopsy specimens. Nephrol Dial Transplant 2001; 16: 11639.
  • 72
    Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP. Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transplant 2006; 21: 6604.
  • 73
    Skluzacek PA, Szewc RG, Nolan CR III, Riley DJ, Lee S, Pergola PE. Prediction of GFR in liver transplant candidates. Am J Kidney Dis 2003; 42: 116976.
  • 74
    MacAulay J, Thompson K, Kiberd BA, Barnes DC, Peltekian KM. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction: are the equations for estimating renal function better? Can J Gastroenterol 2006; 20: 5216.